|
⚲
|
| Keyboard |
| Matis Louis
✚
|
|
|---|---|
| CIK # | 0001650991 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001650991] | |
| 4 | [0001650991] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Palvella Therapeutics Inc | |
| Matis Louis |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Palvella Therapeutics Inc PIRS
Stock Option (Right to Buy) · derivative
|
2019-02-26 | Grant | 96,500 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock Options (Right to buy) · derivative
|
2018-02-20 | Grant | 100,000 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock option (Right to buy) · derivative
|
2017-02-23 | Grant | 145,000 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Common Stock
|
2016-06-14 | Buy | 7,915 | $1.71 | 13,535 |
|
Palvella Therapeutics Inc PIRS
Common Stock
|
2016-06-13 | Buy | 2,085 | $1.68 | 3,503 |
|
Palvella Therapeutics Inc PIRS
Common Stock · derivative
|
2015-08-17 | Grant | 500,000 | $0.00 |